Option Care Health, Inc. - Common Stock (OPCH)
34.12
+0.16 (0.47%)
Option Care Health Inc is a leading provider of home and alternate site infusion services in the United States
The company specializes in delivering personalized intravenous (IV) medication therapies to patients in the comfort of their homes or in outpatient settings, focusing on critical care, oncology, and infectious diseases. Through a network of experienced healthcare professionals, Option Care Health ensures high-quality patient care and treatment, while also emphasizing collaboration with healthcare providers to improve health outcomes and enhance the overall patient experience. The company aims to be a trusted partner in the healthcare continuum, offering innovative solutions tailored to individual patient needs.
Previous Close | 33.96 |
---|---|
Open | 33.83 |
Bid | 33.46 |
Ask | 34.92 |
Day's Range | 33.34 - 34.47 |
52 Week Range | 21.39 - 34.57 |
Volume | 1,879,505 |
Market Cap | 6.14B |
PE Ratio (TTM) | 27.74 |
EPS (TTM) | 1.2 |
Dividend & Yield | N/A (N/A) |
1 Month Average Volume | 1,575,110 |
News & Press Releases

Via Benzinga · February 27, 2025

Alternate site health provider Option Care Health (NASDAQOPCH) beat Wall Street’s revenue expectations in Q4 CY2024, with sales up 19.7% year on year to $1.35 billion. The company’s full-year revenue guidance of $5.4 billion at the midpoint came in 2.5% above analysts’ estimates. Its non-GAAP profit of $0.44 per share was 21.4% above analysts’ consensus estimates.
Via StockStory · February 26, 2025

Senior living provider The Pennant Group (NASDAQPNTG)
will be reporting earnings tomorrow afternoon. Here’s what investors should know.
Via StockStory · February 26, 2025

BANNOCKBURN, Ill., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, announced today financial results for the fourth quarter and full year ended December 31, 2024.
By Option Care Health, Inc. · Via GlobeNewswire · February 26, 2025

Via Benzinga · January 10, 2025

Via Benzinga · December 5, 2024

Alternate site health provider Option Care Health (NASDAQOPCH)
will be reporting earnings tomorrow before market open. Here’s what to look for.
Via StockStory · February 25, 2025

Exploring OPTION CARE HEALTH INC's Technical Signals and Breakout Potential: There are signs that NASDAQ:OPCH may be ready to breakout.
Via Chartmill · February 25, 2025

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how AdaptHealth (NASDAQAHCO) and the rest of the senior health, home health & hospice stocks fared in Q3.
Via StockStory · February 14, 2025

Earnings results often indicate what direction a company will take in the months ahead. With Q3 behind us, let’s have a look at Brookdale (NYSEBKD) and its peers.
Via StockStory · February 14, 2025

Looking back on senior health, home health & hospice stocks’ Q3 earnings, we examine this quarter’s best and worst performers, including Chemed (NYSECHE) and its peers.
Via StockStory · February 14, 2025

Let’s dig into the relative performance of The Pennant Group (NASDAQPNTG) and its peers as we unravel the now-completed Q3 senior health, home health & hospice earnings season.
Via StockStory · February 13, 2025

Earnings results often indicate what direction a company will take in the months ahead. With Q3 behind us, let’s have a look at Option Care Health (NASDAQOPCH) and its peers.
Via StockStory · February 13, 2025

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q3. Today, we are looking at senior health, home health & hospice stocks, starting with BrightSpring Health Services (NASDAQBTSG).
Via StockStory · February 11, 2025

As the Q3 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the senior health, home health & hospice industry, including Addus HomeCare (NASDAQADUS) and its peers.
Via StockStory · February 11, 2025

Via Benzinga · February 10, 2025

After the conclusion of the US market's regular session on Friday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers.
Via Chartmill · January 24, 2025

Via Benzinga · January 23, 2025

Explore this week's top-performing mid-cap stocks, including H&E Equipment Services' impressive 100.59% surge following an acquisition announcement by United Rentals. Discover why stocks like SEMrush and Blueprint Medicines also experienced significant gains, impacting investment portfolios positively.
Via Benzinga · January 19, 2025

Via Benzinga · January 14, 2025

BANNOCKBURN, Ill., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, announced today preliminary unaudited financial results for the fourth quarter and full year ended December 31, 2024.
By Option Care Health, Inc. · Via GlobeNewswire · January 13, 2025

BANNOCKBURN, Ill., Dec. 04, 2024 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (“Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, will participate in the 43rd Annual J.P. Morgan Healthcare Conference, being held in San Francisco, on Monday, January 13, 2025, including a presentation at 1:30pm PT. The webcast and related presentation materials will be available online at https://investors.optioncarehealth.com.
By Option Care Health, Inc. · Via GlobeNewswire · December 4, 2024

BANNOCKBURN, Ill., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (“Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, will participate in the following upcoming investor conferences:
By Option Care Health, Inc. · Via GlobeNewswire · November 6, 2024